ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 939

$1.26M Total Retail Price of All Prescriptions

Rank: 21 out of 939

456 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 456 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 456 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 16,018 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 756 633 1 7
SIMVASTATIN 617 540 2 2
POTASSIUM CHLORIDE 588 519 3 9
HYDROCODONE-ACETAMINOPHEN 560 364 S3 4 1
MELOXICAM 529 434 5 14
OMEPRAZOLE 500 418 6 5
LEVOTHYROXINE SODIUM 496 377 7 4
SERTRALINE HCL 468 357 8 24
AMLODIPINE BESYLATE 462 426 9 6
FLUTICASONE PROPIONATE 417 354 10 43
ATORVASTATIN CALCIUM 296 185 11 22
CYMBALTA 295 185 12 44
ZOLPIDEM TARTRATE 283 218 13 20
CITALOPRAM HBR 267 257 14 15
METOPROLOL SUCCINATE 265 225 15 21
DONEPEZIL HCL 250 242 16 30
GABAPENTIN 238 186 17 11
BUSPIRONE HCL 238 177 17 123
WARFARIN SODIUM 236 186 19 17
MIRTAZAPINE 236 199 19 56
TRAZODONE HCL 220 161 21 26
TAMSULOSIN HCL 214 214 22 27
METFORMIN HCL 210 169 23 8
NEXIUM 203 132 24 18
QUETIAPINE FUMARATE 185 91 25 69
LOSARTAN POTASSIUM 162 150 26 29
HYDROCHLOROTHIAZIDE 159 126 27 12
POLYETHYLENE GLYCOL 3350 158 130 28 57
METOPROLOL TARTRATE 157 111 29 10
DIGOXIN 156 144 30 45
LISINOPRIL 152 137 31 3
NAMENDA 152 152 31 49
TRAMADOL HCL 144 119 33 16
FINASTERIDE 144 143 33 131
ROPINIROLE HCL 141 97 35 78
PRAVASTATIN SODIUM 138 126 36 13
LEVOFLOXACIN 136 114 37 86
TRIAMTERENE-HCTZ 133 118 38 33
NASONEX 119 91 39 247
LOSARTAN-HYDROCHLOROTHIAZIDE 117 116 40 55
NABUMETONE 116 90 41 152
CRESTOR 116 94 41 34
CLOPIDOGREL 112 98 43 28
JANUVIA 112 100 43 110
ESCITALOPRAM OXALATE 110 84 45 61
PREDNISONE 110 86 45 42
IPRATROPIUM BROMIDE 105 86 47 276
SPIRONOLACTONE 103 86 48 71
CELEBREX 103 97 48 106
SYNTHROID 101 65 50 75
ALLOPURINOL 99 86 51 31
VENLAFAXINE HCL ER 95 63 52 121
AMITRIPTYLINE HCL 92 80 R 53 38
OLANZAPINE 91 66 54 135
HALOPERIDOL 91 76 54 169
BENAZEPRIL HCL 88 58 56 87
SINGULAIR 88 54 56 101
ISOSORBIDE MONONITRATE ER 85 62 58 53
FENOFIBRATE 85 65 58 83
OXYCONTIN 83 33 S2 60 161
AZITHROMYCIN 83 64 60 32
PLAVIX 83 74 60 48
ATENOLOL 81 80 63 19
CYCLOBENZAPRINE HCL 81 38 R 63 36
ALENDRONATE SODIUM 80 64 65 40
ADVAIR DISKUS 80 57 65 60
METOLAZONE 79 78 67 181
PRIMIDONE 79 57 67 228
OXYCODONE HCL 75 23 S2 69 67
ESTRADIOL 74 52 R 70 79
LYRICA 72 21 71 63
CARBAMAZEPINE 71 46 72 189
MONTELUKAST SODIUM 71 41 72 172
DOXAZOSIN MESYLATE 71 71 72 108
INDAPAMIDE 70 70 75 173
MORPHINE SULFATE ER 70 35 S2 75 113
NYSTATIN 68 49 77 174
CHLORTHALIDONE 67 62 78 165
FLUDROCORTISONE ACETATE 67 57 78 315
PRADAXA 67 65 78 272
DIOVAN 66 53 81 50
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 54 81 64
CARVEDILOL 64 59 83 25
AVODART 64 61 83 205
TIZANIDINE HCL 64 38 83 81
MECLIZINE HCL 62 60 86 134
TRIAMCINOLONE ACETONIDE 62 52 86 150
ACARBOSE 62 45 86 321
FLUCONAZOLE 62 42 86 140
DICLOFENAC SODIUM 61 46 90 93
LEVETIRACETAM 60 18 91 170
EVISTA 60 59 91 122
SEROQUEL 60 38 91 139
AMITIZA 58 57 94 301
LIPITOR 57 41 95 127
COLCRYS 57 44 95 292
FENTANYL 55 41 S2 97 104
SYMBICORT 54 35 98 137
NITROFURANTOIN MONO-MACRO 54 47 98 180
TRIAMTERENE-HYDROCHLOROTHIAZID 53 51 100 115
BENZTROPINE MESYLATE 53 31 R 100 175
FLUOXETINE HCL 52 52 102 47
CARBIDOPA-LEVODOPA 52 42 102 102
METOCLOPRAMIDE HCL 52 36 102 119
ACTOS 51 49 105 141
VENLAFAXINE HCL 50 33 106 159
PANTOPRAZOLE SODIUM 50 50 106 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.